Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 3
Submit an article Journal homepage
3,156
Views
3
CrossRef citations to date
0
Altmetric
Commentary

Considerations on the clinical development of COVID-19 vaccine from trial design perspectives

Zhiwei Jianga Department of Biostatistics, Beijing KeyTech Statistical Consulting Co., Ltd, Beijing, ChinaCorrespondence[email protected]
,
Xuanyi Wangb Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China
&
Jielai Xiac Department of Health Statistics, Air Force Military Medical University, Xi’an, Shaanxi Province, China
Pages 656-660 | Received 08 May 2020, Accepted 22 Aug 2020, Published online: 29 Sep 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ulrich Kalinke, Dan H. Barouch, Ruben Rizzi, Eleni Lagkadinou, Özlem Türeci, Shanti Pather & Pieter Neels. (2022) Clinical development and approval of COVID-19 vaccines. Expert Review of Vaccines 21:5, pages 609-619.
Read now

Articles from other publishers (2)

Zachary Butzin-Dozier, Tejas S Athni & Jade Benjamin-Chung. (2022) A Review of the Ring Trial Design for Evaluating Ring Interventions for Infectious Diseases. Epidemiologic Reviews 44:1, pages 29-54.
Crossref
Yewon Park, Joo Young Na, Joo-Youn Cho, Jaeseong Oh & Su-jin Rhee. (2022) Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment. Frontiers in Pharmacology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.